Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract

European Journal of Cancer (1965)

Volumn 16, Issue 6, 1980, Pages 859-869

  Sleijfer, Dirk Th ^a   Mulder, Nanno H ^a   de Vries Hospers, Hilly G ^a   Fidler, Vaclav ^a   Nieweg, Hendrik O ^a   van der Waaij, Dirk ^a   van Saene, Hendrik K F ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; COLISTIN A; COTRIMOXAZOLE; NALIDIXIC ACID; UNCLASSIFIED DRUG;

ARTICLE; BLOOD AND HEMOPOIETIC SYSTEM; CANCER; CLINICAL TRIAL; CONTROLLED STUDY; GASTROINTESTINAL TRACT; GRANULOCYTOPENIA; HUMAN; INFECTION; LEUKEMIA; RANDOMIZED CONTROLLED TRIAL; THERAPY; WASTE MANAGEMENT;

ADULT; AGRANULOCYTOSIS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CLINICAL TRIALS; DIGESTIVE SYSTEM; FEMALE; GRAM-NEGATIVE ANAEROBIC BACTERIA; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MYCOSES; YEASTS;

EID: 0018868914     PISSN: 00142964     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2964(80)90140-1     Document Type: Article

References (49)

1. Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia
2. Causes of death in adults with acute leukemia
3. Randomized trial of protected environment-prophylactic antibiotics in 145 adults with acute leukemia
4. Fever and infection in leukemic patients
5. Complications and. Treatment of Acquired Aplastic Anaemia
6. Treatment and prognosis in aplastic anaemia
7. Origin of infection in acute nonlymphocytic leukemia
8. Drug-induced aplastic anaemia
9. Infections in cancer patients on a protected environment-prophylactic antibiotic program
10. Bacterial infection in haematological diseases
11. Protected environments and prophylatic antibiotics
12. Infection by and distribution of biotypes of Enterobacteriaceae species in leukaemic patients treated under ward conditions and in units for protective isolation in seven hospitals in Europe
13. Opportunistic invasive fungal infections in patients with leukaemia and lymphoma
14. Reconventionalization following antibiotic decontamination in man and animals
15. Food and medicaments as possible sources of hospital strains of Pseudomonas aeruginosa
16. Hospital food as a possible source of Escherichia coli in patients
17. Colonization resistance of the digestive tract in conventional and antibiotic-treated mice
18. Determination of the colonization resistance of the digestive tract of individual mice
19. Selective elimination of Enterobacteriaceae species from the digestive tract in mice and monkeys
20. The susceptibility of Bacteroides fragilis to 24 antibiotics
21. Lack of activity of sulfamethoxazole and trimethoprim against anaerobic bacteria
22. Susceptibility of Bacteroides fragilis to 62 antimicrobial agents
23. Combined activity of sulfamethoxazole, trimethoprim, and polymyxin B against Gram-negative bacilli
24. Prophylactic efficacy on nitrofurantoin macrocrystals and trimethoprim-sulfamethoxazole in urinary infections
25. Long-term low-dose co-trimoxazole in prophylaxis of childhood urinary tract infection: bacteriological aspects.
26. Resistance to nalidixic acid
27. Evaluation of accuracy of multitest micromethod system for identification of Enterobacteriaceae.
28. API-system: a multitube method for identification of Enterobacteriaceae
29. Colonization resistance of the digestive tract and the spread of bacteria to the lymphatic organs in mice
30. The effect of nalidixic acid on faecal and vaginal carriage of Enterobacteriaeceae in 54 women
31. The effect of low-dose co-trimoxazole on rectal and vaginal flora
32. Anaerobic infections
33. Trimethoprim-sulfamethoxazole: infection prophylaxis during granulocytopenia
34. High remission-induction rate in acute myeloid leukaemia
35. Amphotericin B concentrations in saliva after application of 2% amphotericin B in Orabase
36. Selective decontamination of the digestive tract in granulocytopenic patients; occurrence of resistance
37. Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection
38. Protected environment-prophylactic antibiotic programmes; microbiological studies
39. Infection prevention in acute non lymphocytic leukemia
40. Successful chemoprophylaxis for Pneumocystis carinii pneumonitis
41. A prospective controlled investigation of prophylactic trimethoprim-sulfamethoxazole in hospitalized granulocytopenic patients
42. Partial antibiotic decontamination